Is there a Wegovy alternative with fewer side effects?

If Wegovy made you feel sick, you are in large company. Nausea, constipation, diarrhea and feeling too full are the most common side effects of every GLP-1 medicine, and they are the most common reason people stop. Before you give up on the whole class, it helps to know two things: how often these side effects happen on each option, and how much of the problem comes from the dose and how fast it goes up rather than the medicine itself.

How common the side effects are

In STEP 1, the main Wegovy trial, 44% of people on semaglutide had nausea at some point, against 17% on placebo, and about three in four had some kind of stomach or bowel side effect. 7% stopped the medicine because of side effects, against 3% on placebo. Most of these effects were mild to moderate and happened while the dose was being increased.

In SURMOUNT-1, the main Zepbound trial, nausea affected between 25% and 33% of people depending on the dose, against about 10% on placebo, and 4% to 7% stopped because of side effects. Those numbers look a little lower than Wegovy's, but they come from different trials with different people, so they are not a fair head-to-head comparison. What we can say is that tirzepatide is not worse, and some people who could not tolerate semaglutide do better on it.

What usually helps more than switching

• A slower dose increase. Side effects cluster in the weeks after each step up. Staying longer at a dose you tolerate, or stepping down for a while, is often enough.
• A lower maintenance dose. Not everyone needs the top dose to keep losing weight; a provider can hold you at the dose that works with the fewest side effects.
• Smaller meals, eaten slowly, and stopping at the first sign of fullness. Large or fatty meals are the most common trigger for nausea and reflux.
• Water and fiber for constipation, and talking to your provider early rather than pushing through.

Our guides on tirzepatide nausea, constipation relief and microdosing go through these step by step. The principle is the same for semaglutide.

When a different medicine makes sense

If side effects persist even at a low dose, switching is reasonable. Some people move from semaglutide to tirzepatide; the switching guide covers how the dose is usually converted. The two GLP-1 pills (the Wegovy pill and Foundayo) have the same kinds of side effects as the injections, so they are a fix for needles, not for nausea. Older non-GLP-1 medicines have their own, different side effects and generally produce less weight loss.

Whatever you try, do not stop and restart on your own at a high dose. Coming back after a break usually means starting again at the bottom of the dose ladder, and a licensed provider should be the one to decide.